Affimed N v (AFMD) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access AFMD Annual Income Statement →
Income statement data covering Affimed N v–Dec 31 2022 offers a view into how Dec 31 2023's operating results have moved alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2023)
Q4 2023
0 0 0 (Dec 31 2022)
Revenues
Sales of Products0.00
Total Revenue9.27
Costs & Expenses
Gross Profit9.27
Selling, Administration, Marketing27.64
Research and Development Expense106.35
OtherOperating Income Expense-5.26
Total operating costs including COS128.73
Operating income / -loss-119.46
Net Interest Expense / -Income0.00
Other loss / -income-0.81
Total costs & expenses127.92
Income & Taxes
Income / -loss before income taxes-118.65
Income taxes expenses / -benefit0.00
Income after income taxes-118.65
Income / -loss from continuing operations-118.65
Net income / -loss-118.65
Income / -loss to shareholder-118.65
EBIT-118.65
EBITD-118.65
EBITDA-118.65
Earnings Per Share
Basic EPS (excl. extra items)-79.41
Basic Net EPS-79.41
Basic shares outstanding (Mill. of Units)0.00
Diluted Net EPS-79.41
Diluted average shares (Mill. of Units)0.00
4 historic quarters locked

Sign in to unlock the full Affimed N v income statement history.

About AFMD Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.